Condition
Engraft Failure
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04945096Phase 3UnknownPrimary
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
NCT03821987Not ApplicableUnknown
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA
NCT03818334Phase 2Recruiting
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Showing all 3 trials